Abstract
Depression-pain dyad involves a series of pathological changes including the dysfunction of neuroendocrine and immune networks. Depression and pain influence each other, but the mechanisms are still obscure. The present study aimed to investigate the effect of ferulic acid (FA) on reserpine-induced pain and depression-like behaviors in mice. The results showed that reserpine (1 mg/kg for 3 days, i.p.) led to a significant decrease in nociceptive threshold in thermal hyperalgesia and mechanical allodynia, as well as a significant increase in the immobility time in mouse models of despair test. The neurochemical assays suggested the decreased neurotransmitters (dopamine, norepinephrine and serotonin) along with the increased oxidative stress, inflammatory cytokines, and apoptotic parameters in the frontal cortex and hippocampus of the reserpinised mice. Treatment with FA (40 or 80 mg/kg, p.o.) reversed the behavioral abnormalities and decreased norepinephrine, serotonin and dopamine levels in the hippocampus and frontal cortex induced by reserpine. The higher dose of FA effectively antagonized the oxidative and nitrosative stress and inflammation as evidenced by down-regulated nitrite, LPO, IL-1β, TNF-α, and up-regulated GSH and SOD. Furthermore, FA produced a dose dependent decrease in substance P, NF-κβ p65 and caspase-3 levels in the frontal cortex and hippocampus of reserpinised mice. The findings suggest that FA exerts the effects on reserpine-induced pain and depression-like behaviors through regulating monoaminergic system, oxidative/antioxidant defense, inflammatory and apoptotic signaling pathways. Understanding the mechanism by which FA ameliorates depression and pain as a multi-targeted compound could open new avenues for the development of innovative treatments for depression coupled with pain.
Similar content being viewed by others
References
Adell A (2004) Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms? Curr Drug Targets CNS Neurol Disord 3:113–121
Arora V, Kuhad A, Tiwari V, Chopra K (2011) Curcumin ameliorates reserpine-induced pain-depression dyad: behavioral, biochemical, neurochemical and molecular evidences. Pychoneuroendocrinology 36:1570–1581
Bair MJ, Robinson RL, Katon W, Kroenke K (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433–2445
Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137–151
Blackwell TS, Christman JW (1997) The role of nuclear factor-κβ in cytokine gene regeneration. Am J Respir Cell Mol Biol 17:3–9
Bourin M, Poncelet M, Chermat R, Simon P (1983) The value of the reserpine test in psychopharmacology. Arzneimittelforschung 33:1173–1176
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 76:248–254
Brightwell JJ, Taylor BK (2009) Noradrenergic neurons in the locus coeruleus contribute to neuropathic pain. Neuroscience 160:174–185
Buege JA, Aust SD (1978) Microsomal lipid-peroxidation. Methods Enzymol 52:302
Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebroke RE, Di Monte DA, Emson PC, Miller GW (2007) Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 27:8138–8148
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63
Chen Z, Hagler J, Palombella VJ, Melandri F, Seherer D, Ballard D, Maniatis T (2012) Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 9:1586–1597
Chopra K, Tiwari V, Arora V, Kuhad A (2010) Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy. J Pain 11:950–957
Duivis HE, de Jonge P, Penninx BW, Na BY, Cohen BE, Whooley MA (2011) Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry 168:913–920
Fernandez MA, Saenz MT, Garcia MD (1998) Anti-inflammatory activity in rats and mice of phenolic acids isolated from Scrophularia frutescens. J Pharm Pharmacol 50:1183–1186
Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego
Golden TR, Hinerfeld DA, Melov S (2002) Oxidative stress and aging: beyond correlation. Aging Cell 1:117–123
Goldenberg DL (2010) Pain/depression dyad, a key to a better understanding and treatment of functional somatic syndromes. Am J Med 123:675–682
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Ann Biochem 126:131–138
Gupta MA (1986) Is chronic pain a variant of depressive illness? A critical review. Can J Psychiatry 31:241–248
Harden RN (2005) Chronic neuropathic pain: mechanisms, diagnosis, and treatment. Neurologist 11:111–122
Ichikawa H, Nakamura Y, Kashiwada Y, Aggarwal BB (2007) Anticancer drugs designed by mother nature: ancient drugs but modern targets. Curr Pharm Des 13:3400–3416
Jackson KC II, St Onge EL (2003) Antidepressant pharmacotherapy: considerations for the pain clinician. Pain Practice 3:135–143
Jaracz J, Rybakowski J (2005) Depression and pain: novel clinical, neurobiological and psychopharmacological data. Psychiatr Pol 39:937–950
Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ (1993) Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 150:734–741
Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189–195
Kumar A, Garg R, Gaur V, Kumar P (2009) Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice. Neurosci Lett 467:72–75
Kumar P, Kalonia H, Kumar A (2011) Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington’s Disease-like symptoms in rats: protective effect of licofelone. Br J Pharmacol 164:644–654
Lee HJ, Lee SY, Kim JH, Sung IK, Park HS, Jin CJ, Kang SG, Yoon H, Chun HJ (2010) Depressive mood and quality of life in functional gastrointerstinal disorders: differences between functional dyspepsia, irritable bowel syndrome and overlap syndrome. Gen Hosp Psychaitry 32:499–502
Lee HR, Hwang IS, Kim JE, Choi SI, Lee YJ, Goo JS, Lee EP, Choi HW, Kim HS, Lee JH, Jung YJ, Hwang DY (2012) Altered expression of r-secretase components in animal model of major depressive disorder induced by reserpine administration. Lab Anim Res 28:109–114
Lepoivre M, Chenais B, Yapo A, Lemaire G, Thelander L, Tenu JP (1990) Alteration of ribonucleotide reductase activity following induction of nitrite generating pathway in adenocarcinoma cells. J Biol Chem 265:14143–14149
Lipowski ZJ (1990) Chronic idiopathic pain syndrome. Ann Med 22:213–217
Maes M (2011) An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuro-Psychopharmacol Biol Psychiatry 35:784–794
Messay B, Lim A, Marsland A (2012) Current understanding of the bi-directional relationship of major depression with inflammation. Biol Mood Disord 2:4
Mico JA, Ardid D, Berrocoso E, Eschalier A (2006) Antidepressants and pain. Trends Pharmacol Sci 27:348–354
Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355–474
Moron MS, Depierre JW, Mannervik B (1979) Levels of reduced glutathione, glutathione reductase and reduced glutathione s-transferase activities in rat lung and liver. BBA Gen Subj 582:67–78
Nagakura Y, Oe T, Aoki T, Matsuoka N (2009) Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia. Pain 146:26–33
Nagakura Y, Takahashi M, Noto T, Sekizawa T, Oe T, Yoshimi E, Tamaki K, Shimizu Y (2012) Different pathophysiology underlying animal models of figromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury rats. Behav Brain Res 226:242–249
Nitta A, Furukawa Y, Hayashi K, Hiramatsu M, Kameyama T, Nabeshima T (1992) Denervation of dopaminergic neurons with 6-hydroxydopamine increases nerve growth factor content in rat brain. Neurosci Lett 144:152
Ogiwara T, Satoh K, Kadoma Y, Murakami Y, Unten S, Atsumi T, Sakagami H, Fujisawa S (2002) Radical scavenging activity and cytotoxicity of ferulic acid. Anticancer Res 22:2711–2717
Ozaki Y (1992) Anti-inflammatory effect of tetramethylpyrazine and ferulic acid. Chem Pharm Bull 40:954–956
Porsolt RD, Pichon MLE, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressant. Arch Int Pharmacodyn Ther 229:327–336
Porsolt RD, Bertin A, Jalfre M (1978) Behavioural despair in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51:291–294
Rojas-Corrales MO (2004) Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. J Psychopharmacol 18:404–411
Sahbaie P, Shi X, Guo TZ, Qiao Y, Yeomans DC, Kingery WS, Clark JD (2009) Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain 145:341–349
Sharma M, Dash SS, Matharasala G, Deekshith V, Sriram D, Yogeeswari P (2012) Novel piperazinyl derivatives with anti-hyperalgesic, anti-allodynic and anti-inflammatory activities useful for the treatment of neuropathic pain. Antiinflamm Antiallergy Agents Med Chem 11:182–190
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85
Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367–370
Szabo C, Ischiropoulos H, Radi R (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6:662–680
Tiwari V, Arora V, Chopra K (2012) Attenuation of NF-κβ mediated apoptotic signaling by tocotrienol ameliorates cognitive deficits in rats postnatally exposed to ethanol. Neurochem Int 61:310–320
Von Korff M, Crane P, Lane M, Miglioretti DL, Simon G, Saunders K, Stang P, Brandenburg N, Kessler R (2005) Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain 113:331–339
Wang BH, Ou-Yang JP (2005) Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovasc Drug Rev 23:161–172
Wills ED (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99:667–676
Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005a) Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82:200–206
Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005b) The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 518:40–46
Yabe T, Hirahara H, Harada N, Ito N, Nagai T, Sanagi T, Yamada H (2010) Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience 165:515–524
Yalcin I, Choucair-Jaafar N, Benbouzid M, Tessier LH, Muller A, Hein L, Freund-Mercier MJ, Barrot M (2009) Beta2-adrenoceptors are critical for antidepressant treatment of neuropathic pain. Ann Neurol 65:218–225
Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407:802–809
Zhang Y, Huang X, Wang Y, Xie Y, Qiu X (2011) Ferulic acid-induced anti-depression and prokinetics similar to Chaihu–Shugan–San via polypharmacology. Brain Res Bull 86:222–228
Acknowledgments
The authors do not have financial or personal conflicts of interest associated with this work. The project was sponsored by National Natural Science Foundation of China (No. 30901802), Wenzhou City Science & Technology Plan Item (No. Y20100201) Wenzhou Science and Technology Bureau Awards to Prof. J. C. Pan (No. Y20080097) and Ruian City Science & Technology Plan Item (No. 201002063). The authors thank Ms. Dorothy Redman for the suggestion that improve the quality of this manuscript.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Ying Xu, Lu Zhang and Tuo Shao contributed equally to this work.
Rights and permissions
About this article
Cite this article
Xu, Y., Zhang, L., Shao, T. et al. Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses. Metab Brain Dis 28, 571–583 (2013). https://doi.org/10.1007/s11011-013-9404-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-013-9404-4